The brain tumor microenvironment

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Glia

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/glia.21264PMID 22379614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• The brain tumor microenvironment

  2011cited by this paper
• Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling.

  2010cited by this paper
• Astrocyte Elevated Gene-1: A Novel Target for Human Glioma Therapy

  2010influential reference
• Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.

  2010influential reference
• Murine Features of Neurogenesis in the Human Hippocampus across the Lifespan from 0 to 100 Years

  2010cited by this paper
• Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

  2010cited by this paper
• Microglial action in glioma: a boon turns bane.

  2010cited by this paper
• Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.

  2010cited by this paper
• Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells.

  2010cited by this paper
• Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.

  2010influential reference
• Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.

  2010cited by this paper
• TRRAP and the maintenance of stemness in gliomas.

  2010cited by this paper
• CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

  2010cited by this paper
• Chemokine CXC receptor 4–mediated glioma tumor tracking by bone marrow–derived neural progenitor/stem cells

  2009cited by this paper
• Glioma-induced remodeling of the neurovascular unit.

  2009cited by this paper
• Biology of angiogenesis and invasion in glioma

  2009cited by this paper
• Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

  2009cited by this paper
• Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft

  2009cited by this paper
• PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain

  2009cited by this paper
• Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion

  2009cited by this paper
• Identification of proteins involved in neural progenitor cell targeting of gliomas

  2009cited by this paper
• Tumor initiating cells in malignant gliomas: biology and implications for therapy

  2009cited by this paper
• Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche.

  2009cited by this paper
• Site‐specific anti‐tumor immunity: Differences in DC function, TGF‐β production and numbers of intratumoral Foxp3+ Treg

  2009cited by this paper
• Reciprocal effects of conditioned medium on cultured glioma cells and neural stem cells.

  2009cited by this paper
• Autophagy-driven cell fate decision maker: Activated microglia induce specific death of glioma cells by a blockade of basal autophagic flux and secondary apoptosis/necrosis

  2009cited by this paper
• Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1.

  2009cited by this paper
• Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Gliomas induce and exploit microglial MT 1-MMP expression for tumor expansion

  2009cited by this paper
• Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.

  2008cited by this paper
• Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition

  2008cited by this paper
• HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.

  2008cited by this paper
• Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas.

  2008influential reference
• A role for the transcription factor HEY1 in glioblastoma

  2008cited by this paper
• Regulation of cell migration and cytokine production by HGF-like protein (HLP) / macrophage stimulating protein (MSP) in primary microglia.

  2008cited by this paper
• Hematopoietic Stem Cell–Derived Pericytic Cells in Brain Tumor Angio-Architecture

  2008cited by this paper
• Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions.

  2008cited by this paper
• Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain.

  2008cited by this paper
• Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• The Antitumorigenic Response of Neural Precursors Depends on Subventricular Proliferation and Age

  2008influential reference
• PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.

  2008cited by this paper
• Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas

  2008cited by this paper
• Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase-1 expression in murine microglia by glioma-derived soluble factors. Laboratory investigation.

  2008cited by this paper
• Stem and progenitor cell-mediated tumor selective gene therapy

  2008cited by this paper
• A specialized vascular niche for adult neural stem cells.

  2008influential reference
• Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling.

  2008cited by this paper
• CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo

  2007cited by this paper
• THE IN VIVO ANTITUMORAL EFFECTS OF LIPOPOLYSACCHARIDE AGAINST GLIOBLASTOMA MULTIFORME ARE MEDIATED IN PART BY TOLL‐LIKE RECEPTOR 4

  2007cited by this paper
• Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

  2007cited by this paper
• Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

  2007cited by this paper
• Increased glioma growth in mice depleted of macrophages.

  2007cited by this paper
• Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.

  2007cited by this paper
• Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.

  2007cited by this paper
• Genetic pathways to primary and secondary glioblastoma.

  2007cited by this paper
• The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.

  2007cited by this paper
• Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

  2007influential reference
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cited by this paper
• Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.

  2007cited by this paper
• A perivascular niche for brain tumor stem cells.

  2007influential reference
• Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells

  2007cited by this paper
• Angiogenesis in brain tumours

  2007cited by this paper
• Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.

  2007cited by this paper
• RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.

  2007cited by this paper
• Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

  2007cited by this paper
• CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas

  2007cited by this paper
• HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.

  2007cited by this paper
• Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

  2006cited by this paper
• An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

  2006cited by this paper
• Notch signaling enhances nestin expression in gliomas.

  2006cited by this paper
• Glial Progenitors in Adult White Matter Are Driven to Form Malignant Gliomas by Platelet-Derived Growth Factor-Expressing Retroviruses

  2006influential reference
• The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

  2006cited by this paper
• Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.

  2006cited by this paper
• Notch, a Universal Arbiter of Cell Fate Decisions

  2006cited by this paper
• Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis

  2006cited by this paper
• Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis.

  2006cited by this paper
• Blood-neural barrier: intercellular communication at glio-vascular interface.

  2006cited by this paper
• Modeling the neurovascular niche: VEGF‐ and BDNF‐mediated cross‐talk between neural stem cells and endothelial cells: An in vitro study

  2006influential reference
• VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain

  2006cited by this paper
• Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

  2006cited by this paper
• Pigment epithelium–derived factor is a niche signal for neural stem cell renewal

  2006cited by this paper
• Microglia function in brain tumors

  2005cited by this paper
• Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2

  2005influential reference
• Angiogenesis as a therapeutic target

  2005cited by this paper
• Glioblastoma-Induced Attraction of Endogenous Neural Precursor Cells Is Associated with Improved Survival

  2005influential reference
• Brain as a paradigm of organ growth: Hedgehog-Gli signaling in neural stem cells and brain tumors.

  2005cited by this paper
• Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis.

  2005cited by this paper
• PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

  2005cited by this paper
• Inhibition of Glioma Cell Proliferation by Neural Stem Cell Factor

  2005cited by this paper
• Normal human fibroblasts enable melanoma cells to induce angiogenesis in type I collagen.

  2005cited by this paper
• Cellular abnormalities of blood vessels as targets in cancer.

  2005cited by this paper
• Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome.

  2005cited by this paper
• Impaired capacity for upregulation of MHC class II in tumor‐associated microglia

  2005cited by this paper
• Endothelial/Pericyte Interactions

  2005cited by this paper
• Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1.

  2005cited by this paper
• Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

  2005cited by this paper
• Neural stem cells and the origin of gliomas.

  2005influential reference
• Neural Progenitor Cell Lines Inhibit Rat Tumor Growth in Vivo

  2004cited by this paper

• Chlorpromazine activates cGAS-STING signaling and reprograms the immune response in glioblastoma.

  2026cites this paper
• The glioma microenvironment and its impact on antitumor immunity

  2025cites this paper
• Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance

  2025cites this paper
• Current State-of-the-Art Animal Models of Pediatric Brain Tumors

  2025cites this paper
• The importance of integrating surgical resection into preclinical glioblastoma modeling.

  2025cites this paper
• Roles of selenium-containing glutathione peroxidases and thioredoxin reductases in the regulation of processes associated with glioblastoma progression.

  2025cites this paper
• Chemoradiation-Altered Micromilieu of Glioblastoma Cells Particularly Impacts M1-like Macrophage Activation

  2025cites this paper
• Synergistic Upregulation of Extracellular Vesicles and Cell-Free Nucleic Acids by Chloroquine and Temozolomide in Glioma Cell Cultures

  2025cites this paper
• Decoding glioblastoma's diversity: are neurons part of the game?

  2025cites this paper
• CAF-derived LRRC15 orchestrates macrophage polarization and limits PD-1 immunotherapy efficacy in glioblastoma.

  2025cites this paper
• Spatial transcriptomic analysis reveals lack of response to PD-1 blockade in recurrent glioblastoma

  2025cites this paper
• Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives.

  2025cites this paper
• Inhibition of hypoxic exosomal miR-423-3p decreases glioma progression by restricting autophagy in astrocytes

  2025cites this paper
• Microglial Inflammatory Response in the Glioblastoma Microenvironment in Preclinical Models

  2025cites this paper
• Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence.

  2025cites this paper
• Introduction of MYBL2 as a common regulator between AHR and RELA: Its relationship with lnc-UCC and lnc-HOTTIP in glioblastoma multiforme

  2024cites this paper
• Gamma-aminobutyric acid-mediated neuro-immune interactions in glioblastoma: Implications for prognosis and immunotherapy response.

  2024cites this paper
• Markers of tumor-associated macrophages and microglia exhibit high intratumoral heterogeneity in human glioblastoma tissue

  2024cites this paper
• Revisiting glioblastoma classification through an immunological lens: A narrative review

  2024cites this paper
• Glioblastoma vaccines: past, present, and opportunities

  2024cites this paper
• A Versatile Microfluidic Device System that Lacks a Synthetic Extracellular Matrix Recapitulates the Blood–Brain Barrier and Dynamic Tumor Cell Interaction

  2024cites this paper
• Glioblastoma: A molecular insight into current discoveries and treatment directions

  2024cites this paper
• Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes

  2024cites this paper
• Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC

  2024cites this paper
• Biological Insights and Radiation–Immuno–Oncology Developments in Primary and Secondary Brain Tumors

  2024cites this paper
• Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches

  2024cites this paper
• Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes

  2024cites this paper
• Segmentation of glioblastomas via 3D FusionNet

  2024cites this paper
• RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages

  2024cites this paper
• Targeting drug resistance in glioblastoma (Review)

  2024cites this paper
• The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma

  2024cites this paper
• The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma

  2023cites this paper
• Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway

  2023cites this paper
• Identifying New Contributors to Brain Metastasis in Lung Adenocarcinoma: A Transcriptomic Meta-Analysis

  2023cites this paper
• Targeting of endothelial cells in brain tumours

  2023cites this paper
• Tumor microenvironment in glioblastoma: Current and emerging concepts

  2023cites this paper
• Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.

  2023cites this paper
• Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment

  2023cites this paper
• Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression

  2023cites this paper
• Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas

  2023cites this paper
• TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages

  2023cites this paper
• EGFR alterations in glioblastoma play a role in antitumor immunity regulation

  2023cites this paper
• Nanomaterials for brain metastasis.

  2023cites this paper
• Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma

  2023cites this paper
• A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors

  2023cites this paper
• From Cells to Organoids: The Evolution of Blood-Brain Barrier Technology for Modelling Drug Delivery in Brain Cancer.

  2023cites this paper
• The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro

  2023cites this paper
• An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?

  2023cites this paper
• Oncogenes and cancer associated thrombosis: what can we learn from single cell genomics about risks and mechanisms?

  2023cites this paper
• Molecular Identity Changes of Tumor-Associated Macrophages and Microglia After Magnetic Resonance Imaging-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Mouse Glioblastoma Model.

  2023cites this paper
• Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme

  2023cites this paper
• Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy

  2023cites this paper
• The Role of Neuro-Inflammation and Innate Immunity in Pathophysiology of Brain and Spinal Cord Tumors.

  2023cites this paper
• Novel approaches to targeting gliomas at the leading/cutting edge.

  2023cites this paper
• Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy

  2023cites this paper
• Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma

  2023cites this paper
• Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme

  2023cites this paper
• Worldwide productivity and research trend of publications concerning glioma-associated macrophage/microglia: A bibliometric study

  2022influential citation
• Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.

  2022cites this paper
• SARM suppresses glioma progression in GL261 glioma cells and regulates microglial polarization

  2022cites this paper
• Tumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization

  2022cites this paper
• RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders

  2022cites this paper
• Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme

  2022cites this paper
• Protocol to assess human glioma propagating cell migration on linear micropatterns mimicking brain invasion tracks

  2022cites this paper
• Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations

  2022cites this paper
• Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective.

  2022cites this paper
• MicroRNA-based therapy for glioblastoma: Opportunities and challenges.

  2022cites this paper
• Astrocytes-Derived Small Extracellular Vesicles Hinder Glioma Growth

  2022cites this paper
• Targeted delivery of irinotecan and SLP2 shRNA with GRP-conjugated magnetic graphene oxide for glioblastoma treatment.

  2022cites this paper
• TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling

  2022cites this paper
• Neuroinflammation: 2022 update.

  2022cites this paper
• Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma

  2022cites this paper
• Tumor Microenvironment in Glioma Invasion

  2022influential citation
• Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue

  2022influential citation
• An Overview of Brain Tumor

  2022cites this paper
• Efficient 3D Spatial Queries for Complex Objects

  2022cites this paper
• Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.

  2022cites this paper
• Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma

  2022cites this paper
• Glioblastoma microenvironment: The stromal interactions.

  2022cites this paper
• Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids

  2022cites this paper
• Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy

  2022cites this paper
• Emerging Biomarkers for Immunotherapy in Glioblastoma

  2022cites this paper
• Paliperidone Inhibits Glioblastoma Growth in Mouse Brain Tumor Model and Reduces PD-L1 Expression

  2021cites this paper
• Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells

  2021cites this paper
• St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity

  2021cites this paper
• Meningioma–Brain Crosstalk: A Scoping Review

  2021cites this paper
• Understanding signal transduction pathways to overcome targeted therapy resistance in glioblastoma

  2021cites this paper
• Hydrogel-Based Spheroid Models of Glioblastoma for Drug Screening Applications.

  2021cites this paper
• Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade

  2021cites this paper
• Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40

  2021cites this paper
• High PYGL Expression Predicts Poor Prognosis in Human Gliomas

  2021cites this paper
• Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate

  2021cites this paper
• Neuroinflammation: A Signature or a Cause of Epilepsy?

  2021cites this paper
• Intratumoral heterogeneity associated with glioblastoma drug response and resistance

  2021cites this paper
• Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage

  2021cites this paper
• The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning

  2021cites this paper
• Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction

  2021cites this paper
• Alterations in CD8+ Tregs, CD56+ Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs)

  2021cites this paper
• Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)

  2021cites this paper
• Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies

  2021cites this paper